Items where Author is "Parkes, M"
Up a level |
LINDSAY, J.O., HIND, D., SWABY, L., BERNTSSON, H., BRADBURN, M., BANNUR C, U., BYRNE, J., CLARKE, C., DESOYSA, L., DICKINS, B., DIN, S., EMSLEY, R., FOULDS, G.A., GRIBBEN, J., HAWKEY, C., IRVING, P.M., KAZMI, M., LEE, E., LOBAN, A., LOBO, A., MAHIDA, Y., MORAN, G.W., PAPAIOANNOU, D., PARKES, M., PENIKET, A., POCKLEY, A.G., SATSANGI, J., SUBRAMANIAN, S., TRAVIS, S., TURTON, E., UTTENTHAL, B., RUTELLA, S. and SNOWDEN, J.A., 2024. Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial. Lancet Gastroenterology and Hepatology. ISSN 2468-1253
SNOWDEN, J.A., HAWKEY, C., HIND, D., SWABY, L., MELLOR, K., EMSLEY, R., MANDEFIELD, L., LEE, E., BADOGLIO, M., POLGE, E., LABOPIN, M., GRIBBEN, J., POCKLEY, A.G., FOULDS, G.A., LOBO, A., TRAVIS, S., PARKES, M., SATSANGI, J., PAPAIOANNOU, D. and LINDSAY, J.O., 2019. Autologous stem cell transplantation in refractory Crohn's disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study. BMC Gastroenterology, 19 (1): 82. ISSN 1471-230X